Experience of Long-Term Afala Treatment in Benign Prostatic Hyperplasia

被引:3
|
作者
Gudkov, A. V. [1 ]
机构
[1] Siberian State Med Univ, Fed Agcy Hlth Care & Social Dev, Tomsk, Russia
关键词
adenoma of the prostate; benign prostatic hyperplasia; afala; LUTS;
D O I
10.1007/s10517-009-0695-8
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The use of ultralow doses of antibodies to prostate-specific antigen (afala) for long-term treatment of benign prostatic hyperplasia in patients with moderate symptoms rapidly and effectively reduces irritative and obstructive symptoms, significantly decreases residual urine volume, and increases the rate of urination. Afala therapy is indicated for patients with stage I-II benign prostatic hyperplasia of moderately pronounced symptoms.
引用
收藏
页码:308 / 311
页数:4
相关论文
共 50 条
  • [1] Experience of Long-Term Afala Treatment in Benign Prostatic Hyperplasia
    A. V. Gudkov
    Bulletin of Experimental Biology and Medicine, 2009, 148
  • [2] Alfuzosin for symptomatic benign prostatic hyperplasia: Long-term experience
    McVary, KT
    JOURNAL OF UROLOGY, 2006, 175 (01): : 35 - 42
  • [3] Long-term outcome of prostatic stent treatment for benign prostatic hyperplasia
    Chiou, RK
    Chen, WS
    Akbari, A
    Foley, S
    Lynch, B
    Taylor, RJ
    UROLOGY, 1996, 48 (04) : 589 - 593
  • [4] Long-term treatment outcome of tamsulosin for benign prostatic hyperplasia
    Ichioka, K
    Ohara, H
    Terada, N
    Matsui, Y
    Yoshimura, K
    Terai, A
    Arai, Y
    INTERNATIONAL JOURNAL OF UROLOGY, 2004, 11 (10) : 870 - 875
  • [5] Long-term results of medical treatment in benign prostatic hyperplasia
    Kim, Chun Il
    Chang, Hyuk Soo
    Kim, Byoung Kun
    Park, Choal Hee
    UROLOGY, 2006, 68 (05) : 1015 - 1019
  • [6] LONG-TERM EXPERIENCE WITH THE PROSTATIC SPIRAL FOR URINARY RETENTION DUE TO BENIGN PROSTATIC HYPERPLASIA
    GUAZZONI, G
    MONTORSI, F
    COLOMBO, R
    DIGIROLAMO, V
    DAPOZZO, L
    RIGATTI, P
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1991, 25 (01): : 21 - 24
  • [7] Experience with the combination of dutasteride and tamsulosin in the long-term management of benign prostatic hyperplasia
    Chughtai, Bilal
    Elterman, Dean S.
    Lee, Richard
    Te, Alexis E.
    Kaplan, Steven A.
    THERAPEUTIC ADVANCES IN UROLOGY, 2012, 4 (05) : 267 - 272
  • [8] NORTH-AMERICAN EXPERIENCE WITH THE UROLUME ENDOPROSTHESIS AS A TREATMENT FOR BENIGN PROSTATIC HYPERPLASIA - LONG-TERM RESULTS
    OESTERLING, JE
    KAPLAN, SA
    EPSTEIN, HB
    DEFALCO, AJ
    REDDY, PK
    CHANCELLOR, MB
    UROLOGY, 1994, 44 (03) : 353 - 362
  • [9] Long-term cost analysis of treatment options for benign prostatic hyperplasia in Norway
    Johansen, Truls E. Bjerklund
    Istad, Jan Anders
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2007, 41 (02): : 124 - 131
  • [10] Long-term 6-year experience with finasteride in patients with benign prostatic hyperplasia
    Lowe, FC
    McConnell, JD
    Hudson, PB
    Romas, NA
    Boake, R
    Lieber, M
    Elhilali, M
    Geller, J
    Imperto-McGinely, J
    Andriole, GL
    Bruskewitz, RC
    Walsh, PC
    Bartsch, G
    Nacey, JN
    Shah, S
    Pappas, F
    Ko, A
    Cook, T
    Stoner, E
    Waldstreicher, J
    UROLOGY, 2003, 61 (04) : 791 - 796